Rallybio logo

Rallybio Share Price (NASDAQ: RLYB)

$0.54

-0.02

(-3.57%)

Last updated on

Check the interactive Rallybio Stock chart to analyse performance

Rallybio stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$0.53
    Today's High:$0.55

    Day's Volatility :3.9%

  • 52 Weeks Low:$0.22
    52 Weeks High:$1.24

    52 Weeks Volatility :82.25%

Rallybio Stock Returns

PeriodRallybio CorpIndex (Russel 2000)
3 Months
86.93%
0.0%
6 Months
-22.58%
0.0%
1 Year
-51.36%
0.0%
3 Years
-95.1%
-4.1%

Rallybio Corp Key Stats

Check Rallybio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.56
Open
$0.5515
Today's High
$0.5515
Today's Low
$0.53
Market Capitalization
$24.6M
Today's Volume
$273.6K
52 Week High
$1.2401
52 Week Low
$0.2201
Revenue TTM
$761.0K
EBITDA
$-41.6M
Earnings Per Share (EPS)
$-0.93
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-66.12%

Stock Returns calculator for Rallybio Stock including INR - Dollar returns

The Rallybio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rallybio investment value today

Current value as on today

₹54,375

Returns

₹45,625

(-45.62%)

Returns from Rallybio Stock

₹50,909 (-50.91%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Rallybio Stock

-76%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Rallybio Stock from India on INDmoney has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Rallybio Corp

  • Name

    Holdings %

  • Viking Global Investors LP

    10.06%

  • Johnson & Johnson

    8.72%

  • 5AM Venture Management, LLC

    8.71%

  • New Leaf Venture Partners, L.L.C.

    7.92%

  • TPG GP A, LLC

    7.26%

  • Pivotal bioVenture Partners Investment Advisor LLC

    5.77%

Analyst Recommendation on Rallybio Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Rallybio(by analysts ranked 0 to 5 stars)

Rallybio Share Price Target

What analysts predicted

Upside of 85.19%

Target:

$1.00

Current:

$0.54

Rallybio share price target is $1.00, a slight Upside of 85.19% compared to current price of $0.54 as per analysts' prediction.

Rallybio Stock Insights

  • Price Movement

    In the last 7 days, RLYB stock has moved down by -14.5%
  • RLYB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 123.4%
  • RLYB vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 211.2%
  • Price to Sales

    ForRLYB every $1 of sales, investors are willing to pay $31.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Rallybio Technicals Summary

Sell

Neutral

Buy

Rallybio is currently in a neutral trading position according to technical analysis indicators.

Rallybio Corp Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Rallybio Corp logo
0.0%
-22.58%
-51.36%
-95.1%
-96.21%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Rallybio Corp

Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody which is in Phase II clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT); and RLYB211 for the prevention of FNAIT. The company is also developing RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. It entered into a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases; and collaboration agreement with Johnson & Johnson to provide pregnant individuals therapeutic solutions at risk of fetal and neonatal alloimmune thrombocytopenia. The company was founded in 2018 and is headquartered in New Haven, Connecticut.
Organization
Rallybio
Employees
20
CEO
Dr. Stephen Uden M.B, M.D.
Industry
Miscellaneous

Key Management of Rallybio Corp

NameTitle
Dr. Martin W. MacKay Ph.D.
Co-Founder & Chairman
Dr. Stephen Uden M.B, M.D.
Co-Founder, President, CEO & Director
Mr. Jonathan I. Lieber M.B.A.
CFO & Treasurer
Dr. Steven W. Ryder F.A.C.P, M.D.
Chief Medical Officer

Important FAQs about investing in RLYB Stock from India :

What is Rallybio share price today?

Rallybio share price today is $0.54 as on at the close of the market. Rallybio share today touched a day high of $0.55 and a low of $0.53.

What is the 52 week high and 52 week low for Rallybio share?

Rallybio share touched a 52 week high of $1.24 and a 52 week low of $0.22. Rallybio stock price today i.e. is closed at $0.54, lower by 56.46% versus the 52 week high.

How to invest in Rallybio Stock (RLYB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rallybio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rallybio Shares that will get you 2.7778 shares as per Rallybio share price of $0.54 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Rallybio Stock (RLYB) from India?

Indian investors can start investing in Rallybio (RLYB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Rallybio stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Rallybio share’s latest price of $0.54 as on August 30, 2025 at 1:29 am IST, you will get 18.5185 shares of Rallybio. Learn more about fractional shares .

What are the returns that Rallybio has given to Indian investors in the last 5 years?

Rallybio stock has given -96.21% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?